Better Buy: Inovio Pharmaceuticals, Inc. vs. Novavax, Inc.
As of now, 2017 is turning out to be a bust for shareholders of both Inovio Pharmaceuticals (NASDAQ: INO) and Novavax (NASDAQ: NVAX). However, both clinical-stage biotech stocks were looking pretty good earlier in the year. Inovio's slump came following a stock offering, while Novavax stock sank on investors' disappointment with a clinical update from the company.
With Inovio and Novavax shares down significantly so far this year, which stock is now the better buy? Here's how the two biotechs compare.
Source: Fool.com